You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.streetinsider.com/Corporate+News/Beam+Therapeutics+%28BEAM%29+to+Sell+Opt-In+Rights+to+Verve+Therapeutics%E2%80%99+Base+Editing+Programs+for+Cardiovascular+Disease+to+Eli+Lilly+for+Up+to+%24600M/22334618.html